Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin (Q36116458)

12 August 2017

Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin (English)

1 reference

12 August 2017

1 reference

L O Dewhurst

1

1 reference

12 August 2017

J W Gee

series ordinal

2

1 reference

12 August 2017

I G Rennie

series ordinal

3

1 reference

12 August 2017

S MacNeil

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

75

1 reference

12 August 2017

6

1 reference

12 August 2017

860-868

1 reference

From adhesion to signalling: roles of integrins in the biology of human melanoma

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Cell-cell and cell-extracellular matrix interactions during melanoma cell invasion and metastasis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Inhibition of malignant tumor cell invasion: an approach to anti-progression.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Calmodulin and Cell Function

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Steroid receptors in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Influence of gender on survival in patients with stage I malignant melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Methyl p-hydroxyphenyllactate. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-II binding sites

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Inhibition of protein kinase C by tamoxifen

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Calmodulin antagonists of improved potency and specificity for use in the study of calmodulin biochemistry

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trials

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

In VitroInteraction of Estradiol Receptor with Ca2+-Calmodulin

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063402

High-affinity anti-oestrogen binding site distinct from the oestrogen receptor

5 December 2018

1 reference

12 December 2020

Survival in metastatic ocular melanoma

1 reference

12 December 2020

Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma

1 reference

12 December 2020

Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years

1 reference

12 December 2020

Survival of patients with metastases from uveal melanoma

1 reference

12 December 2020

High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma

1 reference

12 December 2020

Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin

1 reference

12 December 2020

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen

1 reference

12 December 2020

Properties of a purified estradiol-dependent calf uterus tyrosine kinase

1 reference

12 December 2020

Intracellular regulation of cell adhesion to extracellular matrix components in murine B16 melanoma cells

1 reference

12 December 2020

Inhibition of melanoma cell/matrix interaction by tamoxifen

1 reference

12 December 2020

Down-regulation of transforming growth factor-alpha by tamoxifen in human breast cancer

1 reference

12 December 2020

Chemotherapy for stage 4 melanoma: a three-year experience with cisplatin, DTIC, BCNU, and tamoxifen

1 reference

12 December 2020

Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen

1 reference

12 December 2020

Effect of melanocyte stimulating hormone on human cultured choroidal melanocytes, uveal melanoma cells, and retinal epithelial cells

1 reference

12 December 2020

Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome

1 reference

12 December 2020

Phorbol ester induced rapid attachment and spreading of melanoma cells and the role of extracellular matrix proteins

1 reference

12 December 2020

Investigation of the role of signal transduction in attachment of ocular melanoma cells to matrix proteins: inhibition of attachment by calmodulin antagonists including tamoxifen

1 reference

12 December 2020

Prognostic parameters in localised melanoma: gender versus anatomical location

1 reference

12 December 2020

Tamoxifen and Quercetin Interact with Type II Estrogen Binding Sites and Inhibit the Growth of Human Melanoma Cells

1 reference

12 December 2020

Phase II trial of recombinant interferon-alpha with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma

1 reference

12 December 2020

Prognosis in metastatic choroidal melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.153

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

9062408

1 reference